NPM1 and acute myeloid leukemia: C-terminal mutation of Nucleophosmin 1 (NPM1<sup>C+</sup>) was thought to be a primary driving event in acute myeloid leukemia (AML) that reprograms leukemic-associated transcription programs to transform hematopoietic stem and progenitor cells (HSPCs).